You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NRG1

Showing 1 - 25 of 401
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumors Trial (afatinib)

No longer available
  • Solid Tumors
  • (no location specified)
Nov 7, 2022

NSCLC, Pancreatic Cancer, Locally Advanced Solid Tumor Trial in Sydney (HMBD-001, Docetaxel, Nab-paclitaxel)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • +3 more
  • Sydney, New South Wales, Australia
    GenesisCare North Shore
Jun 16, 2023

Metastatic Pancreatic Cancer Trial in Ottawa (Seribantumab)

Completed
  • Metastatic Pancreatic Cancer
  • Ottawa, Ontario, Canada
    The Ottawa Hospital Cancer Centre
Dec 22, 2021

NSCLC Harboring NRG1 Fusion, Metastatic Castration-resistant Prostate Cancer Trial in Whittier, Lake Mary (Afatinib Oral Tablet,

Recruiting
  • NSCLC Harboring NRG1 Fusion
  • Metastatic Castration-resistant Prostate Cancer
  • Afatinib Oral Tablet
  • +3 more
  • Whittier, California
  • +1 more
Dec 20, 2022

NRG1, NRG1 Fusion, Pancreatic Cancer Trial (MCLA-128)

Available
  • NRG1
  • +11 more
  • (no location specified)
Jul 21, 2021

Afatinib Following Immunotherapy in Treatment of Metastatic,

Completed
  • Non-squamous, Non-Small Cell Lung Cancer
  • Dublin, Ohio
    Cardinal Health
Jan 18, 2022

NRG1-fused NSCLC Trial in Shanghai (Afatinib Dimaleate)

Not yet recruiting
  • NRG1-fused Non-small Cell Lung Cancer
  • Afatinib Dimaleate
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Mar 30, 2021

NSCLC, Stage IV, NSCLC Stage IIIB, NSCLC, Stage IIIC Trial in Canada, Hong Kong, United States (tarloxotinib bromide)

Terminated
  • NSCLC, Stage IV
  • +7 more
  • tarloxotinib bromide
  • Irvine, California
  • +13 more
Nov 11, 2021

NRG - Part 1: Validation of Methods for Estimating Resting

Not yet recruiting
  • Sedentary
  • +2 more
    • Medellín, Antioquia, Colombia
    • +1 more
    Apr 15, 2023

    Oligometastatic Prostate Carcinoma, Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Decatur, Effingham,

    Recruiting
    • Oligometastatic Prostate Carcinoma
    • +2 more
    • Placebo Administration
    • +3 more
    • Decatur, Illinois
    • +2 more
    Aug 11, 2022

    Recurrent Endometrial Carcinoma, Recurrent Endometrial Clear Cell Adenocarcinoma, Recurrent Endometrial Endometrioid

    Not yet recruiting
    • Recurrent Endometrial Carcinoma
    • +8 more
    • BET Bromodomain Inhibitor ZEN-3694
    • +7 more
    • (no location specified)
    Jul 15, 2023

    Platinum-Refractory Fallopian Tube Carcinoma, Platinum-Refractory Ovarian Carcinoma, Platinum-Refractory Primary Peritoneal

    Recruiting
    • Platinum-Refractory Fallopian Tube Carcinoma
    • +11 more
    • Copanlisib Hydrochloride
    • +4 more
    • Aurora, Colorado
    • +2 more
    Dec 8, 2022

    Bladder Cancer Trial in United States (cisplatin, 5-fluorouracil, Mitomycin)

    Active, not recruiting
    Has Results
    • Bladder Cancer
    • Atlanta, Georgia
    • +12 more
    Mar 28, 2022

    Stage II NSCLC AJCC v7, Stage IIA Non-Small Cell Lung Carcinoma AJCC v7, Stage IIB Non-Small Cell Lung Carcinoma AJCC v7 Trial

    Recruiting
    • Stage II Non-Small Cell Lung Cancer AJCC v7
    • +5 more
    • Jacksonville, Florida
    • +29 more
    Dec 15, 2022

    Resectable Soft Tissue Sarcoma, Soft Tissue Sarcoma Trial in United States (Navtemadlin, Radiation Therapy)

    Recruiting
    • Resectable Soft Tissue Sarcoma
    • Soft Tissue Sarcoma
    • Goodyear, Arizona
    • +52 more
    Jul 21, 2022

    Localized Lung Carcinoma, Locally Advanced Lung Non-Small Cell Carcinoma, Recurrent Lung Carcinoma Trial in United States

    Suspended
    • Localized Lung Carcinoma
    • +10 more
    • Accelerated Hypofractionated Radiation Therapy
    • +2 more
    • Atlanta, Georgia
    • +55 more
    Jan 10, 2023

    Glaucoma Trial in Seongnam (Nicotinamide(Mitovita), Placebo)

    Recruiting
    • Glaucoma
    • Nicotinamide(Mitovita)
    • Placebo
    • Seongnam, Bundang-gu, Korea, Republic of
      CHA University Bundang Medical Center
    Oct 9, 2023

    Heart Failure With Reduced Ejection Fraction Trial in United States (JK07, Matching Placebo)

    Active, not recruiting
    • Heart Failure With Reduced Ejection Fraction
    • Tucson, Arizona
    • +6 more
    Jan 30, 2023

    Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer Trial in

    Active, not recruiting
    • Adult Primary Hepatocellular Carcinoma
    • +2 more
    • sorafenib tosylate
    • stereotactic body radiation therapy
    • Berkeley, California
    • +50 more
    Nov 17, 2022

    Brain Metastases Trial in Canada, United States (drug, radiation, procedure)

    Recruiting
    • Brain Metastases
    • Tucson, Arizona
    • +72 more
    Apr 6, 2022

    Cardiotoxicity of Cancer Therapy (CCT)

    Enrolling by invitation
    • Breast Cancer
    • Echocardiography
    • +2 more
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    Feb 14, 2022

    Bladder Cancer, Triple Negative Breast Cancer, Castration-resistant Prostate Cancer Trial in London, Oxford (HMBD-001)

    Recruiting
    • Bladder Cancer
    • +13 more
    • London, United Kingdom
    • +1 more
    Dec 13, 2021

    Brain and CNS Tumors Trial in Canada, United States (54 Gy radiotherapy, 60 Gy radiotherapy)

    Active, not recruiting
    Has Results
    • Brain and Central Nervous System Tumors
    • 54 Gy radiotherapy
    • 60 Gy radiotherapy
    • Phoenix, Arizona
    • +77 more
    Dec 15, 2022

    Stage III Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8 Trial (External Beam Radiation Therapy, Stereotactic Body

    Not yet recruiting
    • Stage III Prostate Cancer AJCC v8
    • Stage IVA Prostate Cancer AJCC v8
    • External Beam Radiation Therapy
    • Stereotactic Body Radiation Therapy
    • (no location specified)
    Jul 20, 2023

    Studies of Neuregulin/ERBB Signaling in Human Heart

    Recruiting
    • Heart Disease
    • +2 more
      • Portland, Maine
        Maine Medical Center
      Nov 22, 2022